Experiment 882618

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationKANTARJIAN,HM: KEATING,MJ: WALTERS,RS: KOLLER,CA: MC CREDIE,KB: FREIREICH,EJ:. (1989). PHASE II STUDY OF LOW-DOSE CONTINUOUS INFUSION HOMOHARRINGTONINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA.. 63(5)
Amount utilized
Compound isolated
DiseaseDOSING FOR 15 TO 21 DAYS IN 13 PATIENTS IN A PHASE 2 STUDY.
Dose amount2.5 MG
Number1
Qualitative resultWEAK ACTIVITY
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE